Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
First Human Receives Experimental Therapy to Reverse Cellular Aging
Get alerts for these topics
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.